Prevalence in ICU
A multicenter, retrospective, real world evidence study to evaluate the prevalence and understand the treatment of ICU infections.
ASSESSMENT OF THERAPY PRESCRIBED
DEMOGRAPHICS and ANTHROPOMETRY
MEDICAL AND SURGICAL HISTORY
| During admission |
|
| During discharge |
|
VITALS (at time of admission, as available)
| Date of Assessment | Parameters | |
|---|---|---|
|
|
PULSE (Bpm) |
|
|
|
BP (mmhg) |
|
|
|
SPO2 (%) |
|
TREATMENT OF CURRENT MEDICAL ILLNESS
| Generic Name | Brand Name | Class | Dose | Frequency | Route | Duration |
|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CONCOMITANT DISEASE and MEDICATION*
| Concomitant Disease | Duration of Disease | Medication | Dose | Frequency |
|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LABORATORY PARAMETERs (at time of admission, as available)
| Date of Assessment | Tests | Results |
|---|---|---|
|
{{-- |
CBC |
{{-- |
|
|
CRP (mg/L) |
|
|
{{-- |
LFT |
{{-- |
|
|
SGPT (U/L) |
|
|
|
SGOT (U/L) |
|
|
{{-- |
RFT |
{{-- |
|
|
S.Cr (mg/dL) |
|
OUTCOMES
ADVERSE EVENTS